European journal revises tumor size guidelines

May 2009
Clinical Trials Administrator;May2009, Vol. 7 Issue 5, p59
This article announces the move by the "European Journal of Cancer," to revise its 2000 guidelines used to measure tumor size, called the Response Evaluation Criteria in Solid Tumors (RESIST). It mentions that clinical trial investigators use RECIST for phase II and phase III studies of new anticancer drugs. Further information on RECIST can be accessed at the journal's web site at www.ejcancer.info.


Related Articles

  • Figures in clinical trial reports: current practice & scope for improvement. Pocock, Stuart J.; Travison, Thomas G.; Wruck, Lisa M. // Trials;2007, Vol. 8, p36 

    Background: Most clinical trial publications include figures, but there is little guidance on what results should be displayed as figures and how. Purpose: To evaluate the current use of figures in Trial reports, and to make constructive suggestions for future practice. Methods: We surveyed all...

  • Not Yet the Last Word on First-in-Man. O'Donnell, Peter // Applied Clinical Trials;Oct2007, Vol. 16 Issue 10, p34 

    The article reflects on the comments of the clinical trial community in Europe to the draft guidance of the European Medicines Agency (EMEA) on the use of man in clinical trials. This draft guidance of the EMEA came about after the unsuccessful first-in-man clinical trial in March 2006, which...

  • Cognitive behavioural therapy in mental health care. Johnson, Charlotte // Healthcare Counselling & Psychotherapy Journal;Jan2005, Vol. 5 Issue 1, p43 

    This article reports on the cognitive behavioural therapy which is high on the agenda of many psychological therapy services because of the recent NICE guidelines promoting it as the preferred treatment of choice for a range of psychological problems. This refreshing book presents a critique of...

  • Expert provides list of basic SOPs for CT sites.  // Clinical Trials Administrator;Mar2011, Vol. 9 Issue 3, p34 

    The article presents the views of Cindy Mendenhall, CCTA, clinical research coordinator, Evergreen Healthcare, Kirkland, Washington, who provides a list of basic standard operating procedures (SOPs) for clinical trial (CT) sites. Included in the list are site selection/initiation visits,...

  • Modifying Clinical Trial Designs to Test Treatments for Clinical Significance in Individual Patients. Becker, R.E. // Clinical Drug Investigation;2001, Vol. 21 Issue 10, p727 

    The aim of this article was to design clinical trials that test treatments for clinical significance in individual patients. In a repeated measures design a scalar summary statistic describes the clinical course of each individual. To provide satisfactory reliability for each patient's clinical...

  • Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials. Avins, Andrew L // Journal of Medical Ethics;Dec98, Vol. 24 Issue 6, p401 

    Examines several techniques for addressing the issue of randomised clinical trials. Suggestion that unbalanced randomisation may be useful for enhancing the ethical design of human experimentation; Approach to the dilemma of equipoise and randomised trials; Methodologic approaches to...

  • CNE/CME questions.  // IRB Advisor;Feb2010, Vol. 10 Issue 2, p24 

    A quiz about issues related to human experimentation in medicine is presented.

  • "Reported and actual trial deaths differ".  // BioSpectrum;Sep2012, Vol. 10 Issue 9, p18 

    The article reports that the Indian health ministry has attributed the cause of majority of reported clinical trial death cases not linked to trials.

  • Allocation bias.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;6/6/2009, Vol. 338 Issue 7707, p1395 

    A quiz about the allocation of people to treatment in clinical trials is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics